Laboratory Medicine ›› 2018, Vol. 33 ›› Issue (4): 376-378.DOI: 10.3969/j.issn.1673-8640.2018.04.023
• Orginal Article • Previous Articles
Received:2017-09-24
Online:2018-04-30
Published:2018-04-26
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2018.04.023
| 项目 | 结果 | 参考区间 |
|---|---|---|
| 钾（mmol/L） | 4.1 | 3.5~5.1 |
| 钠（mmol/L） | 143.0 | 136~145 |
| 氯（mmol/L） | 113.0 | 98~107 |
| 尿素（mmol/L） | 5.9 | 2.8~8.1 |
| 肌酐（μmol/L） | 60.0 | 45~84 |
| TB（μmol/L） | 138.0 | 0~21 |
| DBil（μmol/L） | 4.1 | 0~5 |
| 总蛋白（g/L） | 145.0 | 66~87 |
| 白蛋白（g/L） | 32.0 | 40~49 |
| 球蛋白（g/L） | 113.0 | 20~30 |
| AST（U/L） | 121.0 | 0~32 |
| ALT（U/L） | 102.0 | 7~40 |
| ALP（U/L） | 79.0 | 35~104 |
| GGT（U/L） | 74.0 | 5~36 |
| LDH（U/L） | 428.0 | 135~214 |
| 项目 | 结果 | 参考区间 |
|---|---|---|
| 钾（mmol/L） | 4.1 | 3.5~5.1 |
| 钠（mmol/L） | 143.0 | 136~145 |
| 氯（mmol/L） | 113.0 | 98~107 |
| 尿素（mmol/L） | 5.9 | 2.8~8.1 |
| 肌酐（μmol/L） | 60.0 | 45~84 |
| TB（μmol/L） | 138.0 | 0~21 |
| DBil（μmol/L） | 4.1 | 0~5 |
| 总蛋白（g/L） | 145.0 | 66~87 |
| 白蛋白（g/L） | 32.0 | 40~49 |
| 球蛋白（g/L） | 113.0 | 20~30 |
| AST（U/L） | 121.0 | 0~32 |
| ALT（U/L） | 102.0 | 7~40 |
| ALP（U/L） | 79.0 | 35~104 |
| GGT（U/L） | 74.0 | 5~36 |
| LDH（U/L） | 428.0 | 135~214 |
| 检测日期 | κ轻链（g/L） | TB（μmol/L） |
|---|---|---|
| 2016-08-27 | 29.8 | 138.0 |
| 2016-09-19 | 8.9 | 41.8 |
| 2016-10-12 | 2.4 | 16.7 |
| 检测日期 | κ轻链（g/L） | TB（μmol/L） |
|---|---|---|
| 2016-08-27 | 29.8 | 138.0 |
| 2016-09-19 | 8.9 | 41.8 |
| 2016-10-12 | 2.4 | 16.7 |
| [1] | 沈敏娜,吴炯,郭玮,等. M蛋白干扰对血清样本常规生化检测项目的影响[J]. 检验医学,2011,26(11):730-735. |
| [2] | YANG Y,HOWANITZ P J,HOWANITZ J H,et al.Paraproteins are a common cause of interferences with automated chemistry methods[J]. Arch Pathol Lab Med,2008,132(2):217-223. |
| [3] | PANTANOWITZ L,HOROWITZ G L,UPALAKALIN J N,et al.Artifactual hyperbilirubinemia due to paraprotein interference[J].Arch Pathol Lab Med,2003,127(1):55-59. |
| [4] | NAUTI A,BARASSI A,MERLINI G,et al.Paraprotein interference in an assay of conjugated bilirubin[J]. Clin Chem,2005,51(6):1076-1077. |
| [5] | NANDA S K,SARANGI R,RAY L,et al.Factitious biochemical reports which are caused due to paraproteinaemia in multiple myeloma-a case report[J]. J Clin Diagn Res,2013,7(2):350-352. |
| [6] | DATTA P,GRAHAM G A,SCHOEN I.Interference by IgG paraproteins in the Jaffe method for creatinine determination[J]. Am J Clin Pathol,1986,85(4):463-468. |
| [7] | CHAKRABORTY S,SEN S,GUPTA D,et al.Spurious hyperphosphatemia in a case of multiple myeloma[J]. Indian J Clin Biochem,2014,29(2):250-252. |
| [8] | VAN GORSELEN E O,DIEKMAN T,HESSELS J,et al. Artifactual measurement of low serum HDL-cholesterol due to paraproteinemia[J]. Clin Res Cardiol,2010,99(9):599-602. |
| [9] | AOKI Y J,KAMEKO M,FUJITA K.A case of IgG4-lambda type monoclonal immunoglobulin that interfered with determinations for albumin,direct bilirubin and iron in serum[J]. Rinsho Byori,2001,49(7):686-689. |
| [10] | DUTTA A K.A curious case of hyperbilirubinemia[J]. Indian J Clin Biochem,2012,27(2):200-201. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
